Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of FGFR mutant gene panels in identifying cancer patients that will be responsive to treatment with an FGFR inhibitor

Use of FGFR mutant gene panels in identifying cancer patients that will be responsive to treatment with an FGFR inhibitor

US Patent 12037644 · Granted Jul 16, 2024

Estimated economic value: $1,861,723,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biological markers for identifying patients for treatment with abiraterone aceta2021
FGFR/PD-1 combination therapy for the treatment of cancer2019
FGFR/PD-1 combination therapy for the treatment of cancer2019
Assay for predictive biomarkers2018